Detalhe da pesquisa
1.
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.
Future Oncol
; 20(14): 891-901, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189180
2.
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Cancer
; 129(14): 2256-2265, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151113
3.
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1103-1115, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779531
4.
Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2- advanced breast cancer.
J Clin Oncol
; : JCO2400144, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771995
5.
Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial.
J Thorac Oncol
; 18(6): 755-768, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001859
6.
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations.
J Thorac Oncol
; 18(11): 1581-1593, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541389
7.
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study.
J Clin Oncol
; 40(31): 3593-3602, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605188
8.
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.
Nat Med
; 28(11): 2374-2380, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008722
9.
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
Clin Cancer Res
; 27(14): 3884-3895, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947690
10.
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study.
J Thorac Oncol
; 16(9): 1547-1558, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607312
11.
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.
Nat Med
; 26(11): 1733-1741, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32895571